Astellas Pharma Inc. (TYO:4503)

Astellas Pharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 30, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	3,852,010	2,589,390	2,946,773	3,381,409	3,519,738	3,161,421
Market Cap Growth	40.92%	-12.13%	-12.85%	-3.93%	11.33%	1.80%
Enterprise Value	4,305,495	3,324,889	3,565,926	3,003,971	3,170,189	2,856,153
Last Close Price	2150.50	1412.19	1531.31	1690.42	1661.58	1441.59
PE Ratio	30.95	51.03	172.88	34.26	28.37	26.22
Forward PE	16.60	18.73	21.06	15.87	16.50	15.21
PS Ratio	1.92	1.35	1.84	2.23	2.72	2.53
PB Ratio	2.39	1.71	1.85	2.24	2.41	2.28
P/TBV Ratio	24.33	-	-	5.48	6.59	7.02
P/FCF Ratio	10.52	16.44	21.92	11.61	15.53	11.48
P/OCF Ratio	9.64	13.31	17.09	10.32	13.67	10.30
PEG Ratio	0.29	0.17	1.48	0.68	0.70	2.26
EV/Sales Ratio	2.15	1.74	2.22	1.98	2.45	2.29
EV/EBITDA Ratio	7.69	7.19	12.63	8.90	10.64	8.83
EV/EBIT Ratio	11.77	12.62	28.62	12.97	14.53	11.38
EV/FCF Ratio	11.76	21.11	26.53	10.31	13.98	10.37
Debt / Equity Ratio	0.46	0.62	0.63	0.14	0.15	0.20
Debt / EBITDA Ratio	1.32	2.03	3.57	0.61	0.72	0.86
Debt / FCF Ratio	2.02	5.95	7.50	0.70	0.94	1.01
Asset Turnover	0.58	0.55	0.53	0.63	0.56	0.54
Inventory Turnover	1.32	1.28	1.38	1.76	1.60	1.56
Quick Ratio	0.76	0.79	0.69	1.13	1.05	1.15
Current Ratio	1.03	1.13	0.93	1.45	1.34	1.47
Return on Equity (ROE)	7.95%	3.26%	1.10%	6.65%	8.72%	9.01%
Return on Assets (ROA)	6.68%	4.77%	2.58%	6.05%	5.92%	6.83%
Return on Invested Capital (ROIC)	15.96%	11.63%	4.72%	12.83%	12.80%	15.28%
Return on Capital Employed (ROCE)	17.40%	11.60%	5.50%	13.40%	13.30%	14.90%
Earnings Yield	3.24%	1.96%	0.58%	2.92%	3.52%	3.81%
FCF Yield	9.50%	6.08%	4.56%	8.62%	6.44%	8.71%
Dividend Yield	3.64%	5.24%	4.57%	3.55%	3.01%	2.91%
Payout Ratio	106.09%	254.19%	684.38%	101.66%	68.69%	63.15%
Buyback Yield / Dilution	0.07%	0.14%	1.39%	1.38%	0.41%	1.03%
Total Shareholder Return	3.71%	5.38%	5.96%	4.93%	3.42%	3.94%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.